Growth Hormone Deficiency after Treatment of Acromegaly: A Randomized, Placebo-Controlled Study of Growth Hormone Replacement
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
CONTEXT: The effects of GH replacement therapy in patients who develop GH deficiency (GHD) after cure of acromegaly have not been established in a placebo-controlled study. OBJECTIVE: The objective of the study was to determine whether GH replacement improves body composition, cardiovascular risk markers and quality of life in patients with GHD and prior acromegaly. DESIGN: This was a 6-month, randomized, placebo-controlled study. SETTING: The study was conducted at a clinical translational science center. STUDY PARTICIPANTS: Participants included 30 subjects with prior acromegaly and current GHD. INTERVENTION: INTERVENTIONs included GH or placebo. MAIN OUTCOME MEASURES: Body composition (dual-energy x-ray absorptiometry and cross-sectional computed tomography at L4), cardiovascular risk markers (high-sensitivity C-reactive protein (hsCRP), total, high-density lipoprotein and low-density lipoprotein cholesterol, fibrinogen, and carotid intimal-medial thickness), and quality of life were measured. RESULTS: The mean GH dose at 6 months was 0.58 +/- 0.26 mg/d. Total fat mass, visceral adipose tissue (-15.3 +/- 18.6 vs. 1.3 +/- 12.5%, P = 0.01), and total abdominal fat decreased, and fat-free mass increased, in the GH vs. placebo group. Mean hsCRP levels decreased, but there was no GH effect on other cardiovascular risk markers. There was no change in glycosylated hemoglobin or homeostasis model assessment insulin resistance index. Quality of life improved with GH. Side effects were minimal. CONCLUSIONS: This is the first randomized, placebo-controlled study of the effects of GH replacement therapy on body composition and cardiovascular end points in patients who have developed GH deficiency after treatment for acromegaly, a disease complicated by metabolic and body composition alterations and increased cardiovascular risk. GH replacement decreased visceral adipose tissue, increased fat-free mass, decreased hsCRP, and improved quality of life in patients with GHD after cure of acromegaly, with minimal side effects and without an increase in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rates of pituitary axes recovery or new onset hypopituitarism after transsphenoidal surgery vary significantly between studies (115,233,234).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [233]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
Fujioka, S., Matsuzawa, Y., Tokunaga, K., & Tarui, S. (1987) · Metabolism · doi:10.1016/0026-0495(87)90063-1 · Cited by 1,207
Treatment of obesity: need to focus on high risk abdominally obese patients
Després, J.-P., Lemieux, I., & Prud'homme, D. (2001) · BMJ · doi:10.1136/bmj.322.7288.716 · Cited by 826
(1987) · PubMed · Cited by 439
Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency
Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8509 · Cited by 423
Self-citationMaison, P., Griffin, S., Nicoue-Beglah, M., Haddad, N., Balkau, B., & Chanson, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030840 · Cited by 362
Cardiovascular risk factors in adult patients with growth hormone deficiency
Rosén, T., Edén, S., Larson, G., Wilhelmsen, L., & Bengtsson, B.-Å. (1993) · Acta Endocrinologica · doi:10.1530/acta.0.1290195 · Cited by 338
Which Patients Do Not Require a GH Stimulation Test for the Diagnosis of Adult GH Deficiency?
Hartman, M. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.477 · Cited by 319
Self-citationBurman, P. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3585 · Cited by 290
Weaver, J. U. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.1.153 · Cited by 282
Baum, H. B. A., Biller, B. M. K., Finkelstein, J. S., Cannistraro, K. B., Oppenheim, D. S., Schoenfeld, D. A., Michel, T. H., Wittink, H., & Klibanski, A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-11-199612010-00003 · Cited by 277
Self-citationMcGAULEY, G. A. (1989) · Acta Paediatrica · doi:10.1111/j.1651-2227.1989.tb11249.x · Cited by 265
McKenna, S. P., Doward, L. C., Alonso, J., Kohlmann, T., Niero, M., Prieto, L., & Wíren, L. (1999) · Quality of Life Research · doi:10.1023/a:1008987922774 · Cited by 263
Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults1
Pfeifer, M., Verhovec, R., Zizek, B., Prezelj, J., Poredos, P., & Clayton, R. N. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5456 · Cited by 260
Sesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00010 · Cited by 257
Self-citationBiermasz, N. R., van Thiel, S. W., Pereira, A. M., Hoftijzer, H. C., van Hemert, A. M., Smit, J. W. A., Romijn, J. A., & Roelfsema, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0669 · Cited by 254
The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults1
Cuneo, R. C., Judd, S., Wallace, J. D., Perry-Keene, D., Burger, H., Lim-Tio, S., Strauss, B., Stockigt, J., Topliss, D., Alford, F., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4482 · Cited by 245
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1158 · Cited by 230
Koutkia, P., Canavan, B., Breu, J., Torriani, M., Kissko, J., & Grinspoon, S. (2004) · JAMA · doi:10.1001/jama.292.2.210 · Cited by 215
The GH–IGF‐I axis and the cardiovascular system: clinical implications
Colao, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03292.x · Cited by 209
Biermasz, N. R., Pereira, A. M., Smit, J. W. A., Romijn, J. A., & Roelfsema, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2297 · Cited by 209
McGauley, G. A., Cuneo, R. C., Salomon, F., & Sönksen, P. H. (1990) · Hormone Research · doi:10.1159/000181584 · Cited by 190
Hoffman, A. R., Kuntze, J. E., Baptista, J., Baum, H. B. A., Baumann, G. P., Biller, B. M. K., Clark, R. V., Cook, D., Inzucchi, S. E., Kleinberg, D., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030346 · Cited by 185
Self-citationDe Boer, H. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.833 · Cited by 182
Long-Term Follow-Up Results of Postoperative Radiotherapy in 36 Patients with Acromegaly
Biermasz, N. R., Dulken, H. V., & Roelfsema, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2476 · Cited by 179
Lavie, C. J., & Milani, R. V. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1878 · Cited by 179
Van Der Klaauw, A. A., Kars, M., Biermasz, N. R., Roelfsema, F., Dekkers, O. M., Corssmit, E. P., Van Aken, M. O., Havekes, B., Pereira, A. M., Pijl, H., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03288.x · Cited by 175
Baum, H. B. A., Katznelson, L., Sherman, J. C., Biller, B. M. K., Hayden, D. L., Schoenfeld, D. A., Cannistraro, K. E., & Klibanski, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5112 · Cited by 174
Self-citationThe Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults
Cuneo, R. C. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.107 · Cited by 171
Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults
Pfeifer, M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.453 · Cited by 160
Body composition in growth hormone deficient adults
Binnerts, A., Deurenberg, P., Swart, G., Wilson, J., & Lamberts, S. W. J. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.5.918 · Cited by 159 · cited 3×
“J Clin Endocrinol Metab, February 2010, 95(2):567–577 jcem.”
BackgroundGharib, H., Cook, D. M., Saenger, P. H., Bengtsson, B.-A., Feld, S., Nippoldt, T. B., Rodbard, H. W., Seibel, J. A., Vance, M. L., Zimmerman, D., et al. (2003) · Endocrine Practice · doi:10.4158/ep.9.1.64 · Cited by 158
Quality of Life of Adults with Growth Hormone Deficiency: a Controlled Study
BJORK, S., JONSSON, B., WESTPHAL, O., & LEVIN, J. ‐. (1989) · Acta Paediatrica · doi:10.1111/j.1651-2227.1989.tb11242.x · Cited by 135 · cited 1×
“treatment of nonsomatotroph tumors (2, 3, 8, 45, 46).”
BackgroundHypertension in acromegaly and in the normal population: prevalence and determinants
Vitale, G., Pivonello, R., Auriemma, R. S., Guerra, E., Milone, F., Savastano, S., Lombardi, G., & Colao, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02370.x · Cited by 129
Borson-Chazot, F., Serusclat, A., Kalfallah, Y., Ducottet, X., Sassolas, G., Bernard, S., Labrousse, F., Pastene, J., Sassolas, A., Roux, Y., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5595 · Cited by 128
Lamarche, B. (1998) · Coronary Artery Disease · doi:10.1097/00019501-199809080-00002 · Cited by 123
Increased arterial intima‐media thickness by B‐M mode echodoppler ultrasonography in acromegaly
Colao, A., Spiezia, S., Cerbone, G., Pivonello, R., Marzullo, P., Ferone, D., Di Somma, C., Assanti, A. P., & Lombardi, G. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01256.x · Cited by 121
Italian Validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ) *
Fava, G. A., Kellner, R., Perini, G. I., Fava, M., Michelacci, L., Munari, F., Evangelisti, L. P., Grandi, S., Bernardi, M., & Mastrogiacomo, I. (1983) · The Canadian Journal of Psychiatry · doi:10.1177/070674378302800208 · Cited by 118
Barreto-Filho, J. A. S. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2018 · Cited by 100
Beauregard, C., Utz, A. L., Schaub, A. E., Nachtigall, L., Biller, B. M. K., Miller, K. K., & Klibanski, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2371 · Cited by 99
Self-citationQuality of Life in Treated Patients with Acromegaly
Kauppinen-Mäkelin, R., Sane, T., Sintonen, H., Markkanen, H., Välimäki, M. J., Löyttyniemi, E., Niskanen, L., Reunanen, A., & Stenman, U.-H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0676 · Cited by 99
Inflammatory cardiovascular risk markers in women with hypopituitarism
Sesmilo, G., Miller, K. K., Hayden, D., & Klibanski, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8087 · Cited by 97
Self-citationPerahia, D. G., Gilaberte, I., Wang, F., Wiltse, C. G., Huckins, S. A., Clemens, J. W., Montgomery, S. A., Montejo, A. L., & Detke, M. J. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.4.346 · Cited by 94
Feldt-Rasmussen, U., Abs, R., Bengtsson, B., Bennmarker, H., Bramnert, M., Hernberg-Stahl, E., Monson, J., Westberg, B., Wilton, P., & Wuster, C. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460067 · Cited by 84
Wexler, T., Gunnell, L., Omer, Z., Kuhlthau, K., Beauregard, C., Graham, G., Utz, A. L., Biller, B., Nachtigall, L., Loeffler, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2671 · Cited by 69
Self-citationColao, A., Di Somma, C., Rota, F., Pivonello, R., Savanelli, M. C., Spiezia, S., & Lombardi, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2247 · Cited by 62
Attanasio, A. F., Shavrikova, E. P., Blum, W. F., & Shalet, S. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0439 · Cited by 56
Factors influencing the desire for long‐term growth hormone replacement in adults
Holmes, S. J., & Shalet, S. M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01909.x · Cited by 53
Calculation of energy expenditure from indirect calorimetry: assessment of the Weir equation.
Cunningham, J. J. (1990) · PubMed · Cited by 52
van der Klaauw, A. A., Bax, J. J., Roelfsema, F., Stokkel, M. P. M., Bleeker, G. B., Biermasz, N. R., Smit, J. W. A., Romijn, J. A., & Pereira, A. M. (2009) · Pituitary · doi:10.1007/s11102-009-0186-y · Cited by 41
Norrman, L.-L., Johannsson, G., Sunnerhagen, K. S., & Svensson, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2673 · Cited by 37
Somatic Symptoms in Outpatients With Major Depressive Disorder Treated With Fluoxetine
Denninger, J. W., Papakostas, G. I., Mahal, Y., Merens, W., Alpert, J. E., Nierenberg, A. A., Yeung, A., & Fava, M. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.4.348 · Cited by 34
Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments
Ronchi, C. L., Giavoli, C., Ferrante, E., Verrua, E., Bergamaschi, S., Ferrari, D. I., Corbetta, S., Montefusco, L., Arosio, M., Ambrosi, B., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0222 · Cited by 34
Gómez, J. M., Sahún, M., Vila, R., Domènech, P., Catalina, P., Soler, J., & Badimón, L. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02518.x · Cited by 30
Devin, J. K., Blevins, L. S., Verity, D. K., Chen, Q., Bloodworth, J. R., Covington, J., & Vaughan, D. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0609 · Cited by 30
The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients
Murray, R. D., Peacey, S. R., Rahim, A., Toogood, A. A., Thorner, M. O., & Shalet, S. M. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01189.x · Cited by 29
van der Klaauw, A. A., Pereira, A. M., van Thiel, S. W., Smit, J. W. A., Corssmit, E. P. M., Biermasz, N. R., Frolich, M., Iranmanesh, A., Veldhuis, J. D., Roelfsema, F., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02163 · Cited by 24
Research works printed but not linked: 1
- Holmes SJ, McKenna SP, Doward LC, Hunt SM, Shalet SM 1995 Development of a questionnaire to access the quality of life of adults with growth hormone deficiency. Endocrinol Metab 2:63–69 [Google Scholar]
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
(2011) · Endocrine Practice · doi:10.4158/ep.17.s4.1 · Cited by 259
Self-citation
Metadata
- Authors
- Miller, K. K., Wexler, T., Fazeli, P., Gunnell, L., Graham, G. J., Beauregard, C., Hemphill, L., Nachtigall, L., Loeffler, J., Swearingen, B., Biller, B. M. K., & Klibanski, A.
- Affiliations
- Harvard University (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-02-01
- Volume
- 95
- Issue
- 2
- Pages
- 567-577
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2840863
- OpenAlex
- W2115440430
- Semantic Scholar
- 423eb15f74da2ba72493543ea0684569e547e5d7
- Cited by
- 66
- References
- 64
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 7 · 2014: 6 · 2013: 4 · 2012: 13
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Harvard Catalyst
- National Heart, Lung, and Blood Institute (K24HL092902)
- National Center for Research Resources (MO1 RR01066, M01RR001066, ULI RR0257801)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- growth hormone deficiency, acromegaly, growth hormone replacement therapy, body composition, visceral adipose tissue, fat-free mass, cardiovascular risk markers, C-reactive protein, carotid intima-media thickness, quality of life, insulin resistance
- MeSH terms
- Acromegaly, Adult, Aged, Body Composition, C-Reactive Protein, Female, Humans, Male, Middle Aged, Quality of Life, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.